We opportunistically included a chikungunya envelope 1 recombinant virus antigen (CHIKV
E1), a dengue 2 virus-like protein (DENV-2 VLP), and a DENV-3 VLP in a multiplex bead …

Background: Indonesia reports the second highest dengue disease burden in the world.
However these passive surveillance data are recognized to be incomplete, to vary widely …

Objective To differentiate exposure to the newly introduced chikungunya virus from
exposure to endemic dengue virus and other pathogens in Haiti. Methods We used a …

Background The dengue vaccine (Dengvaxia) is only recommended for individuals with
prior dengue infection (PDI). This study aimed to perform a serosurvey to inform decision …

Dengue is the most significant arthropod-borne viral infection of humans. Persons infected
with dengue viruses (DENV) have subclinical or clinically apparent infections ranging from …

Dengue and chikungunya viruses are frequent causes of malarial-like febrile illness in
children. The rapid increase in virus transmission by mosquitoes is a global health concern …

Background Dengue fever is the world's fastest spreading mosquito borne viral infection. It is
prevalent throughout both subtropical and tropical region, and affects over 128 countries …

Background Detection of dengue virus antibodies is important for understanding future
dengue virus risk and for prevaccination screening. We aimed to evaluate the performance …

Background The first documented outbreak of dengue which included cases with
haemorrhage occurred in Papua New Guinea in 2016. Aim To document the presentation …

Dengue and chikungunya are now widely distributed in Cameroon, but there is still not
enough information on their prevalence in different epidemiological settings. This study was …